Together with Muscular Dystrophy Canada (MDC) we are pleased to invite you to our CPD-Accredited webinar ‘Understanding the molecular mechanisms of Myotonic dystrophy Type 1 to develop therapeutic strategies’. This webinar is primarily targeted at Canadian clinicians, academics, and trainees with an interest in neuromuscular disease.

Chair:

• Dr. Élise Duchesne

Agenda:

• Dr. Nicolas Dumont: Muscle stem cell defects in Myotonic Dystrophy Type 1: physiopathology and therapeutic avenues
• Dr. Vladimir Ljubicic: Exercise is muscle mitochondrial medicine in DM1

Learning Objectives:

1. Myotonic dystrophy type 1 (DM1).
2. The extent of skeletal muscle impairments experienced by individuals living with DM1.
3. The fundamental molecular mechanisms that underlie this disease.
4. Present and future therapeutic avenues for addressing muscular impairments in DM1.

NMD4C and MDC are providing organizational and technical support. This is an independent clinical/academic webinar with no industry sponsorship or influence. The NMD Rounds & Educational Webinars is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.